The Development of Stem Cell-Derived Exosomes as a Cell-Free Regenerative Medicine
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
A successful strategy in regenerative medicine\nover the last decade has been the translation of stem cell\ntherapy to repair diseased or damaged tissue in a wide\nrange of indications, despite limited evidence attributing\nany therapeutic benefit to cell survival or differentiation.\nRecent findings, however, have demonstrated that the\nconditioned media from stem cell cultures can produce\nsimilar efficacious effects compared to those observed for\ncells. This has led to the stem cell paracrine hypothesis,\nproposing that secreted factors released from the stem\ncells contribute significantly to their beneficial effects. It\nhas been well documented that stem cells have the ability\nto release a range of growth factors, cytokines and\nchemokines relevant to their function; however, these\nfactors are released at levels too low to account for the\nreported therapeutic effects. Further purification of the\nconditioned media has since identified that not only are\nsmall molecules released by the stem cells, but so too are\na large quantity of membrane-bound vesicles, including\nexosomes, in a functionally relevant manner. In this\nreview, we present our current understanding and\nexplore the evidence supporting the development of stem\ncell-derived exosomes as a cell-free regenerative\nmedicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., & Turbide, C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48095-7 · Cited by 2,931 · cited 1×
“Unlike MVs, which are derived from plasma membrane shedding, exosomes are secreted by multivesicular bodies (MVBs) [38, 41-44].”
BackgroundSecretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., & Ochiya, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.107821 · Cited by 1,934 · cited 1×
“The bilayer membrane encapsulation of exosomes provides a protected and controlled internal microenvironment, allowing cargo to travel long distances within tissues without degradation [27, 28, 54-56].”
BackgroundHarding, C., Heuser, J., & Stahl, P. (1983) · The Journal of Cell Biology · doi:10.1083/jcb.97.2.329 · Cited by 1,775 · cited 1×
“Unlike MVs, which are derived from plasma membrane shedding, exosomes are secreted by multivesicular bodies (MVBs) [38, 41-44].”
BackgroundExport of microRNAs and microRNA-protective protein by mammalian cells
Wang, K., Zhang, S., Weber, J., Baxter, D., & Galas, D. J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq601 · Cited by 1,002
Webber, J., & Clayton, A. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.19861 · Cited by 817
Membrane Microparticles: Two Sides of the Coin
Hugel, B., Martínez, M. C., Kunzelmann, C., & Freyssinet, J.-M. (2005) · Physiology · doi:10.1152/physiol.00029.2004 · Cited by 698 · cited 2×
“Exosomes are lipid bilayer-bound vesicles, released from cells after stimulation [40], and they express specific biomarkers independently of the cell source that will be detailed below.”
BackgroundCollino, F., Deregibus, M. C., Bruno, S., Sterpone, L., Aghemo, G., Viltono, L., Tetta, C., & Camussi, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011803 · Cited by 608
Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease
Lai, R. C., Chen, T. S., & Lim, S. K. (2011) · Regenerative Medicine · doi:10.2217/rme.11.35 · Cited by 553 · cited 2×
“However, the paracrine hypothesis has been strengthened by the recent discovery that stem cells release not only soluble factors but also extracellular vesicles which elicit similar biological activity to the stem cells themselves [11-14].”
BackgroundTransfer of MicroRNAs by Embryonic Stem Cell Microvesicles
Yuan, A., Farber, E. L., Rapoport, A. L., Tejada, D., Deniskin, R., Akhmedov, N. B., & Farber, D. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004722 · Cited by 416 · cited 2×
“transcription, proliferation and cell immune regulation [57-60].”
Background
Cited by
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491
Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine
Vizoso, F., Eiro, N., Cid, S., Schneider, J., & Perez-Fernandez, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091852 · Cited by 1,363
“The soluble components of the secretome may be separated from the microvesicle fraction by centrifugation, filtration, polymer precipitation-based methodologies, ion exchange chromatography and size-exclusion chromatography [52,53].”
BackgroundMethodMesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications
Rani, S., Ryan, A. E., Griffin, M. D., & Ritter, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.44 · Cited by 1,227
Harrell, C., Fellabaum, C., Jovicic, N., Djonov, V., Arsenijevic, N., & Volarevic, V. (2019) · Cells · doi:10.3390/cells8050467 · Cited by 501
Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing
Didiot, M.-C., Hall, L. M., Coles, A. H., Haraszti, R. A., Godinho, B. M., Chase, K., Sapp, E., Ly, S., Alterman, J. F., Hassler, M. R., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.126 · Cited by 483
“Neural stem cells or exosomes derived from stem cells are being considered as a therapeutic modality for the treatment of stroke 47,48 or neurodegenerative disorders.”
BackgroundLiu, X., Yang, Y., Li, Y., Niu, X., Zhao, B., Wang, Y., Bao, C., Xie, Z., Lin, Q., & Zhu, L. (2017) · Nanoscale · doi:10.1039/c7nr00352h · Cited by 465
Konala, V. B. R., Mamidi, M. K., Bhonde, R., Das, A. K., Pochampally, R., & Pal, R. (2016) · Cytotherapy · doi:10.1016/j.jcyt.2015.10.008 · Cited by 451
Manufacturing Exosomes: A Promising Therapeutic Platform
Colao, I. L., Corteling, R., Bracewell, D., & Wall, I. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.01.006 · Cited by 396
Self-citationConcise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles
Reiner, A. T., Witwer, K. W., van Balkom, B. W. M., de Beer, J., Brodie, C., Corteling, R. L., Gabrielsson, S., Gimona, M., Ibrahim, A. G., de Kleijn, D., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0055 · Cited by 345
Self-citationRoles of exosomes in cardioprotection
Barile, L., Moccetti, T., Marbán, E., & Vassalli, G. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw304 · Cited by 294
Ludwig, A., De Miroschedji, K., Doeppner, T. R., Börger, V., Ruesing, J., Rebmann, V., Durst, S., Jansen, S., Bremer, M., Behrmann, E., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1528109 · Cited by 291
Zhai, M., Zhu, Y., Yang, M., & Mao, C. (2020) · Advanced Science · doi:10.1002/advs.202001334 · Cited by 277
Toward Exosome-Based Therapeutics: Isolation, Heterogeneity, and Fit-for-Purpose Potency
Willis, G. R., Kourembanas, S., & Mitsialis, S. A. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00063 · Cited by 257
Metadata
- Authors
- Vishnubhatla, I., Corteling, R., Stevanato, L., Hicks, C., & Sinden, J.
- Venue
- Journal of Circulating Biomarkers
- Publisher
- Aboutscience Srl
- Published
- 2014-01
- Volume
- 3
- Pages
- 2
- ISSN
- 1849-4544 (ISSN-L)
- OpenAlex
- W2160527837
- Cited by
- 81
- References
- 9
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.